Q1 2020 13F Holders as of 3/31/2020
-
Type / Class
-
Equity / Common Stock, par value $0.001 par value per share
-
Shares outstanding
-
73.8M
-
Number of holders
-
42
-
Total 13F shares, excl. options
-
9.36M
-
Shares change
-
+2.82M
-
Total reported value, excl. options
-
$319M
-
Value change
-
+$94.7M
-
Number of buys
-
26
-
Number of sells
-
-15
-
Price
-
$34.11
Significant Holders of RELMADA THERAPEUTICS, INC. - Common Stock, par value $0.001 par value per share (RLMD) as of Q1 2020
53 filings reported holding RLMD - RELMADA THERAPEUTICS, INC. - Common Stock, par value $0.001 par value per share as of Q1 2020.
RELMADA THERAPEUTICS, INC. - Common Stock, par value $0.001 par value per share (RLMD) has 42 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 9.36M shares
of 73.8M outstanding shares and own 12.68% of the company stock.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, L.P. (1.38M shares), TANG CAPITAL MANAGEMENT LLC (1.3M shares), Avoro Capital Advisors LLC (1.15M shares), RTW INVESTMENTS, LP (985K shares), VR Adviser, LLC (843K shares), VANGUARD GROUP INC (580K shares), BlackRock Inc. (478K shares), PARSONS CAPITAL MANAGEMENT INC/RI (426K shares), CITADEL ADVISORS LLC (320K shares), and BOXER CAPITAL, LLC (300K shares).
This table shows the top 42 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.